Unexpected Efficacy Signal

Unexpected efficacy signal identifies greater-than-anticipated therapeutic benefit warranting investigation. Off-target mechanism engagement produces additional benefits. Patient population enrichment explains enhanced response. Dosing regimen optimization improves efficacy. Biomarker discovery predicts responsive populations.

Clinical investigation characterises signal mechanisms. Regulatory notification informs about signal findings. Labelling updates communicate new indications. Post-approval exploration validates signal sustainability. Emerging populations may reveal additional benefits.